210 related articles for article (PubMed ID: 28852062)
1. Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage.
Gai Z; Chu L; Xu Z; Song X; Sun D; Kullak-Ublick GA
Sci Rep; 2017 Aug; 7(1):9815. PubMed ID: 28852062
[TBL] [Abstract][Full Text] [Related]
2. A naturally occurring FXR agonist, alisol B 23-acetate, protects against renal ischemia-reperfusion injury.
Luan ZL; Ming WH; Sun XW; Zhang C; Zhou Y; Zheng F; Yang YL; Guan YF; Zhang XY
Am J Physiol Renal Physiol; 2021 Nov; 321(5):F617-F628. PubMed ID: 34569253
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.
Gai Z; Gui T; Hiller C; Kullak-Ublick GA
J Biol Chem; 2016 Jan; 291(5):2397-411. PubMed ID: 26655953
[TBL] [Abstract][Full Text] [Related]
4. The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD.
Kim DH; Park JS; Choi HI; Kim CS; Bae EH; Ma SK; Kim SW
Cell Death Dis; 2021 Mar; 12(4):320. PubMed ID: 33767132
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis.
Xu Y; Li D; Wu J; Zhang M; Shao X; Xu L; Tang L; Zhu M; Ni Z; Zhang M; Mou S
Cell Prolif; 2021 Apr; 54(4):e13005. PubMed ID: 33594777
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury.
Zhu JB; Xu S; Li J; Song J; Luo B; Song YP; Zhang ZH; Chen YH; Xie DD; Yu DX; Xu DX
Eur J Pharmacol; 2018 Nov; 838():60-68. PubMed ID: 30196109
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Nuclear Receptor Fxr Improves Intestinal Cell Tolerance to Ischemia-Reperfusion Injury.
Wang X; Li S; Chen M; Liu J; Dong R; Wang H; Zhu S
Shock; 2018 Sep; 50(3):316-323. PubMed ID: 29028769
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.
Xiong C; Zang X; Zhou X; Liu L; Masucci MV; Tang J; Li X; Liu N; Bayliss G; Zhao TC; Zhuang S
Oncotarget; 2017 May; 8(19):31238-31253. PubMed ID: 28415724
[TBL] [Abstract][Full Text] [Related]
9. Activation of sirtuin1 protects against ischemia/reperfusion-induced acute kidney injury.
Gong L; He J; Sun X; Li L; Zhang X; Gan H
Biomed Pharmacother; 2020 May; 125():110021. PubMed ID: 32092826
[TBL] [Abstract][Full Text] [Related]
10. Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury.
Efrati S; Berman S; Hamad RA; Siman-Tov Y; Ilgiyaev E; Maslyakov I; Weissgarten J
Nephrol Dial Transplant; 2012 Jan; 27(1):136-45. PubMed ID: 21680852
[TBL] [Abstract][Full Text] [Related]
11. Porous Se@SiO
Zheng Z; Deng G; Qi C; Xu Y; Liu X; Zhao Z; Zhang Z; Chu Y; Wu H; Liu J
Int J Nanomedicine; 2019; 14():215-229. PubMed ID: 30643402
[TBL] [Abstract][Full Text] [Related]
12. Diosmetin protects against ischemia/reperfusion-induced acute kidney injury in mice.
Yang K; Li WF; Yu JF; Yi C; Huang WF
J Surg Res; 2017 Jun; 214():69-78. PubMed ID: 28624062
[TBL] [Abstract][Full Text] [Related]
13. The protein kinase 2 inhibitor tetrabromobenzotriazole protects against renal ischemia reperfusion injury.
Ka SO; Hwang HP; Jang JH; Hyuk Bang I; Bae UJ; Yu HC; Cho BH; Park BH
Sci Rep; 2015 Oct; 5():14816. PubMed ID: 26423352
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-21 by Ghrelin Ameliorates Ischemia/Reperfusion-Induced Acute Kidney Injury by Inhibiting Inflammation and Cell Apoptosis.
Zhang W; Shu L
DNA Cell Biol; 2016 Aug; 35(8):417-25. PubMed ID: 27152763
[TBL] [Abstract][Full Text] [Related]
15. Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats.
Ceulemans LJ; Verbeke L; Decuypere JP; Farré R; De Hertogh G; Lenaerts K; Jochmans I; Monbaliu D; Nevens F; Tack J; Laleman W; Pirenne J
PLoS One; 2017; 12(1):e0169331. PubMed ID: 28060943
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes.
Kim DH; Choi HI; Park JS; Kim CS; Bae EH; Ma SK; Kim SW
Redox Biol; 2022 Aug; 54():102382. PubMed ID: 35767918
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.
Lian F; Xing X; Yuan G; Schäfer C; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP; Burgermeister E
Biochem J; 2011 Sep; 438(2):315-23. PubMed ID: 21619550
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cell-Derived Conditioned Medium Attenuates Acute Kidney Injury by Downregulating the Oxidative Stress-Related Pathway in Ischemia-Reperfusion Rats.
Tarng DC; Tseng WC; Lee PY; Chiou SH; Hsieh SL
Cell Transplant; 2016; 25(3):517-30. PubMed ID: 26132529
[TBL] [Abstract][Full Text] [Related]
19. The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1: a comparison with infliximab treatment.
Di Paola R; Genovese T; Impellizzeri D; Ahmad A; Cuzzocrea S; Esposito E
Eur J Pharmacol; 2013 Jan; 700(1-3):134-46. PubMed ID: 23291313
[TBL] [Abstract][Full Text] [Related]
20. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice.
Toyohara T; Mae S; Sueta S; Inoue T; Yamagishi Y; Kawamoto T; Kasahara T; Hoshina A; Toyoda T; Tanaka H; Araoka T; Sato-Otsubo A; Takahashi K; Sato Y; Yamaji N; Ogawa S; Yamanaka S; Osafune K
Stem Cells Transl Med; 2015 Sep; 4(9):980-92. PubMed ID: 26198166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
